Tissue distribution and gender-divergent expression of 78 cytochrome p450 mRNAs in mice

Toxicological Sciences

Volumn 124, Issue 2, 2011, Pages 261-277

  Renaud, Helen J ^a   Cui, Julia Yue ^a   Khan, Mohammed ^a   Klaassen, Curtis D ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Cytochrome P450; Mice; MRNA; Tissue distribution

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2A; CYTOCHROME P450 2A12; CYTOCHROME P450 2A22; CYTOCHROME P450 2A4; CYTOCHROME P450 2A5; CYTOCHROME P450 2B; CYTOCHROME P450 2B10; CYTOCHROME P450 2B13; CYTOCHROME P450 2B23; CYTOCHROME P450 2B9; CYTOCHROME P450 2C; CYTOCHROME P450 2C29; CYTOCHROME P450 2C37; CYTOCHROME P450 2C38; CYTOCHROME P450 2C39; CYTOCHROME P450 2C40; CYTOCHROME P450 2D; CYTOCHROME P450 2D10; CYTOCHROME P450 2D22; CYTOCHROME P450 2D9; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; CYTOCHROME P450 3A11; CYTOCHROME P450 3A16; CYTOCHROME P450 4A; CYTOCHROME P4502B19; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; FEMALE; GENE CLUSTER; GENE EXPRESSION; GENE REARRANGEMENT; MALE; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; TISSUE DISTRIBUTION;

ANIMALS; BLOTTING, WESTERN; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; INTESTINE, SMALL; ISOENZYMES; KIDNEY; LIVER; MALE; MICE; MICE, INBRED C57BL; ORGAN SPECIFICITY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEX CHARACTERISTICS; TESTIS; XENOBIOTICS;

EID: 81855199725     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfr240     Document Type: Article

References (58)

1. Al-Anizy, M., Horley, N. J., Kuo, C. W., Gillett, L. C., Laughton, C. A., Kendall, D., Barrett, D. A., Parker, T., and Bell, D. R. (2006). Cytochrome P450 Cyp4x1 is a major P450 protein in mouse brain. FEBS J. 273, 936-947.
2. Aleksunes, L. M., Cui, Y., and Klaassen, C. D. (2008). Prominent expression of xenobiotic efflux transporters in mouse extraembryonic fetal membranes compared with placenta. Drug Metab. Dispos. 36, 1960-1970.
3. Alnouti, Y., and Klaassen, C. D. (2006). Tissue distribution and ontogeny of sulfotransferase enzymes in mice. Toxicol. Sci. 93, 242-255.
4. Alnouti, Y., and Klaassen, C. D. (2008). Tissue distribution, ontogeny, and regulation of aldehyde dehydrogenase (Aldh) enzymes mRNA by prototypical microsomal enzyme inducers in mice. Toxicol. Sci. 101, 51-64.
5. Anderson, G. D. (2005). Sex and racial differences in pharmacological response: Where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J. Womens Health (Larchmt) 14, 19-29.
6. Audet-Walsh, E., Auclair-Vincent, S., and Anderson, A. (2009). Glucocorticoids and phenobarbital induce murine CYP2B genes by independent mechanisms. Expert Opin. Drug Metab. Toxicol. 5, 1501-1511.
7. Banov, M. D., Tohen, M., and Friedberg, J. (1993). High risk of eosinophilia in women treated with clozapine. J. Clin. Psychiatry 54, 466-469.
8. Bornheim, L. M., Kim, K. Y., Chen, B., and Correia, M. A. (1995). Microsomal cytochrome P450-mediated liver and brain anandamide metabolism. Biochem. Pharmacol. 50, 677-686.
9. Burkhart, B. A., Harada, N., and Negishi, M. (1985). Sexual dimorphism of testosterone 15 alpha-hydroxylase mRNA levels in mouse liver. cDNA cloning and regulation. J. Biol. Chem. 260, 15357-15361.
10. Bylund, J., Zhang, C., and Harder, D. R. (2002). Identification of a novel cytochrome P450, CYP4X1, with unique localization specific to the brain. Biochem. Biophys. Res. Commun. 296, 677-684.
11. Cheng, X., and Klaassen, C. D. (2009). Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys. Drug Metab. Dispos. 37, 2178-2185.
12. Cheng, X., Maher, J., Chen, C., and Klaassen, C. D. (2005). Tissue distribution and ontogeny of mouse organic anion transporting polypeptides (Oatps). Drug Metab. Dispos. 33, 1062-1073.
13. Choudhary, D., Jansson, I., Schenkman, J. B., Sarfarazi, M., and Stoilov, I. (2003). Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch. Biochem. Biophys. 414, 91-100.
14. Cui, Y. J., Cheng, X., Weaver, Y. M., and Klaassen, C. D. (2009). Tissue distribution, gender-divergent expression, ontogeny, and chemical induction of multidrug resistance transporter genes (Mdr1a, Mdr1b, Mdr2) in mice. Drug Metab. Dispos. 37, 203-210.
15. Damon, M., Fautrel, A., Marc, N., Guillouzo, A., and Corcos, L. (1996). Isolation of a new mouse cDNA clone: Hybrid form of cytochrome P450 2b10 and NADPH-cytochrome P450 oxidoreductase. Biochem. Biophys. Res. Commun. 226, 900-905.
16. Gandhi, M., Aweeka, F., Greenblatt, R. M., and Blaschke, T. F. (2004). Sex differences in pharmacokinetics and pharmacodynamics. Annu. Rev. Pharmacol. Toxicol. 44, 499-523.
17. Hedlund, E., Gustafsson, J. A., and Warner, M. (2001). Cytochrome P450 in the brain; a review. Curr. Drug Metab. 2, 245-263.
18. Heng, Y. M.,Kuo,C. S., Jones, P. S., Savory, R., Schulz, R. M., Tomlinson, S.R., Gray, T. J., and Bell, D. R. (1997). A novel murine P-450 gene, Cyp4a14, is part of a cluster of Cyp4a and Cyp4b, but not of CYP4F, genes in mouse and humans. Biochem. J. 325(Pt 3), 741-749.
19. Hernandez, J. P., Chapman, L. M., Kretschmer, X. C., and Baldwin, W. S. (2006). Gender-specific induction of cytochrome P450s in nonylphenoltreated FVB/NJ mice. Toxicol. Appl. Pharmacol. 216, 186-196.
20. Hernandez, J. P., Mota, L. C., Huang, W., Moore, D. D., and Baldwin, W. S. (2009). Sexually dimorphic regulation and induction of P450s by the constitutive androstane receptor (CAR). Toxicology 256, 53-64.
21. Hiroi, T., Imaoka, S., and Funae, Y. (1998). Dopamine formation from tyramine by CYP2d6. Biochem. Biophys. Res. Commun. 249, 838-843.
22. Holloway, M. G., Cui, Y., Laz, E. V., Hosui, A., Hennighausen, L., and Waxman, D. J. (2007). Loss of sexually dimorphic liver gene expression upon hepatocyte-specific deletion of Stat5a-Stat5b locus. Endocrinology 148, 1977-1986.
23. Honkakoski, P., Moore, R., Gynther, J., and Negishi, M. (1996). Characterization of phenobarbital-inducible mouse Cyp2b10 gene transcription in primary hepatocytes. J. Biol. Chem. 271, 9746-9753.
24. Hrycay, E. G., and Bandiera, S. M. (2009). Expression, function and regulation of mouse cytochrome P450 enzymes: Comparison with human P450 enzymes. Curr. Drug Metab. 10, 1151-1183.
25. Hu, Z. Y., and Zhao, Y. S. (2010). Sex-dependent differences in cytochrome P450 3A activity as assessed by midazolam disposition in humans: A metaanalysis. Drug Metab. Dispos. 38, 817-823.
26. Imaoka, S., Hiroi, T., Tamura, Y., Yamazaki, H., Shimada, T., Komori, M., Degawa, M., and Funae, Y. (1995). Mutagenic activation of 3-methoxy-4-aminoazobenzene by mouse renal cytochrome P450 CYP4B1: Cloning and characterization of mouse CYP4B1. Arch. Biochem. Biophys. 321, 255-262.
27. Jarukamjorn, K., Sakuma, T., Miyaura, J., and Nemoto, N. (1999). Different regulation of the expression of mouse hepatic cytochrome P450 2B enzymes by glucocorticoid and phenobarbital. Arch. Biochem. Biophys. 369, 89-99.
28. Jarukamjorn, K., Sakuma, T., and Nemoto, N. (2000). Discriminating activation of CYP2B9 expression in male C57BL/6 mouse liver by betaestradiol. Biochem. Biophys. Res. Commun. 279, 288-292.
29. Jarukamjorn, K., Sakuma, T., and Nemoto, N. (2002). Sexual dimorphic expression of mouse hepatic CYP2B: Alterations during development or after hypophysectomy. Biochem. Pharmacol. 63, 2037-2041.
30. Jarukamjorn, K., Sakuma, T., Yamamoto, M., Ohara, A., and Nemoto, N. (2001). Sex-associated expression of mouse hepatic and renal CYP2B enzymes by glucocorticoid hormones. Biochem. Pharmacol. 62, 161-169.
31. Kakizaki, S., Yamamoto, Y., Ueda, A., Moore, R., Sueyoshi, T., and Negishi, M. (2003). Phenobarbital induction of drug/steroid-metabolizing enzymes and nuclear receptor car. Biochim. Biophys. Acta 1619, 239-242.
32. Keeney, D. S., Skinner, C., Travers, J. B., Capdevila, J. H., Nanney, L. B., King, L. E., Jr., and Waterman, M. R. (1998). Differentiating keratinocytes express a novel cytochrome P450 enzyme, CYP2BL9, having arachidonate monooxygenase activity. J. Biol. Chem. 273, 32071-32079.
33. Lofgren, S., Baldwin, R. M., Carleros, M., Terelius, Y., Fransson-Steen, R., Mwinyi, J., Waxman, D. J., and Ingelman-Sundberg, M. (2009). Regulation of human CYP2C18 and CYP2C19 in transgenic mice: Influence of castration, testosterone, and growth hormone. Drug Metab. Dispos. 37, 1505-1512.
34. Ma, J., Qu, W., Scarborough, P. E., Tomer, K. B., Moomaw, C. R., Maronpot, R., Davis, L. S., Breyer, M. D., and Zeldin, D. C. (1999). Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome P450 highly expressed in kidney. J. Biol. Chem. 274, 17777-17788.
35. Muller, D. N., Schmidt, C., Barbosa-Sicard, E., Wellner, M., Gross, V., Hercule, H., Markovic, M., Honeck, H., Luft, F. C., and Schunck, W. H. (2007). Mouse Cyp4a isoforms: Enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation. Biochem. J. 403, 109-118.
36. Nebert, D. W., Nelson, D. R., and Feyereisen, R. (1989). Evolution of the cytochrome P450 genes. Xenobiotica 19, 1149-1160.
37. Nelson, D. R., Zeldin, D. C., Hoffman, S. M., Maltais, L. J., Wain, H. M., and Nebert, D. W. (2004). Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14, 1-18.
38. Nemoto, N., and Sakurai, J. (1995). Glucocorticoid and sex hormones as activating or modulating factors for expression of Cyp2b-9 and Cyp2b-10 in the mouse liver and hepatocytes. Arch. Biochem. Biophys. 319, 286-292.
39. Park, S. H., Liu, X., Hennighausen, L., Davey, H. W., and Waxman, D. J. (1999). Distinctive roles of STAT5a and STAT5b in sexual dimorphism of hepatic P450 gene expression. Impact of STAT5a gene disruption. J. Biol. Chem. 274, 7421-7430.
40. Pass, G. J., Becker, W., Kluge, R., Linnartz, K., Plum, L., Giesen, K., and Joost, H. G. (2002). Effect of hyperinsulinemia and type 2 diabetes-like hyperglycemia on expression of hepatic cytochrome p450 and glutathione stransferase isoforms in a New Zealand obese-derived mouse backcross population. J. Pharmacol. Exp. Ther. 302, 442-450.
41. Qu, W., Bradbury, J. A., Tsao, C. C., Maronpot, R., Harry, G. J., Parker, C. E., Davis, L. S., Breyer, M. D., Waalkes, M. P., Falck, J. R., et al. (2001). Cytochrome P450 CYP2J9, a new mouse arachidonic acid omega-1 hydroxylase predominantly expressed in brain. J. Biol. Chem. 276, 25467-25479.
42. Rajapaksa, K. S., Sipes, I. G., and Hoyer, P. B. (2007). Involvement of microsomal epoxide hydrolase enzyme in ovotoxicity caused by 7,12-dimethylbenz[a]anthracene. Toxicol. Sci. 96, 327-334.
43. Rapoport, S. I., Chang,M. C., and Spector, A. A. (2001). Delivery and turnover of plasma-derived essential PUFAs inmammalian brain. J. Lipid Res. 42, 678-685.
44. Sakuma, T., Endo, Y., Mashino, M., Kuroiwa, M., Ohara, A., Jarukamjorn, K., and Nemoto, N. (2002). Regulation of the expression of two femalepredominant CYP3A mRNAs (CYP3A41 and CYP3A44) in mouse liver by sex and growth hormones. Arch. Biochem. Biophys. 404, 234-242.
45. Sakuma, T., Takai, M., Endo, Y., Kuroiwa, M., Ohara, A., Jarukamjorn, K., et al. (2000). A novel female-specific member of the CYP3A gene subfamily in the mouse liver. Arch. Biochem. Biophys. 377, 153-162.
46. Schuppe, H. C., Wieneke, P., Donat, S., Fritsche, E., Kohn, F. M., and Abel, J. (2000). Xenobiotic metabolism, genetic polymorphisms and male infertility. Andrologia 32, 255-262.
47. Shimada, T., Sugie, A., Shindo, M., Nakajima, T., Azuma, E., Hashimoto, M., and Inoue, K. (2003). Tissue-specific induction of cytochromes P450 1A1 and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in engineered C57BL/6J mice of arylhydrocarbon receptor gene. Toxicol. Appl. Pharmacol. 187, 1-10.
48. Smith, D. A. (1991). Species differences in metabolism and pharmacokinetics: Are we close to an understanding? Drug Metab. Rev. 23, 355-373.
49. Sobocanec, S., Balog, T., Saric, A., Sverko, V., Zarkovic, N., Gasparovic, A. C., Zarkovic, K., Waeg, G., Macak-Safranko, Z., and Kusic, B. (2010). Cyp4a14 overexpression induced by hyperoxia in female CBA mice as a possible contributor of increased resistance to oxidative stress. Free Radic. Res. 44, 181-190.
50. Stark, K., Dostalek, M., and Guengerich, F. P. (2008). Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide. FEBS J. 275, 3706-3717.
51. Tanaka, E. (1999). Gender-related differences in pharmacokinetics and their clinical significance. J. Clin. Pharm. Ther. 24, 339-346.
52. Tran, C., Knowles, S. R., Liu, B. A., and Shear, N. H. (1998). Gender differences in adverse drug reactions. J. Clin. Pharmacol. 38, 1003-1009.
53. van Iersel, M., Walters, D. G., Price, R. J., Lovell, D. P., and Lake, B. G. (1994). Sex and strain differences in mouse hepatic microsomal coumarin 7-hydroxylase activity. Food Chem. Toxicol. 32, 387-390.
54. Wang, H., Zhao, Y., Bradbury, J. A., Graves, J. P., Foley, J., Blaisdell, J. A., Goldstein, J. A., and Zeldin, D. C. (2004). Cloning, expression, and characterization of three new mouse cytochrome p450 enzymes and partial characterization of their fatty acid oxidation activities. Mol. Pharmacol. 65, 1148-1158.
55. Waterston, R. H., Lindblad-Toh, K., Birney, E., Rogers, J., Abril, J. F., Agarwal, P., Agarwala, R., Ainscough, R., Alexandersson, M., An, P., et al. (2002). Initial sequencing and comparative analysis of the mouse genome. Nature 420, 520-562.
56. Waxman, D. J., and Holloway, M. G. (2009). Sex differences in the expression of hepatic drug metabolizing enzymes. Mol. Pharmacol. 76, 215-228.
57. Wiwi, C. A., Gupte, M., and Waxman, D. J. (2004). Sexually dimorphic P450 gene expression in liver-specific hepatocyte nuclear factor 4alpha-deficient mice. Mol. Endocrinol. 18, 1975-1987.
58. Wolbold, R., Klein, K., Burk, O., Nussler, A. K., Neuhaus, P., Eichelbaum, M., Schwab, M., and Zanger, U. M. (2003). Sex is a major determinant of CYP3A4 expression in human liver. Hepatology 38, 978-988.